First Wave BioPharma
Stock Forecast, Prediction & Price Target

First Wave BioPharma Financial Estimates

First Wave BioPharma Revenue Estimates

First Wave BioPharma EBITDA Estimates

First Wave BioPharma Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $16.47M
Low: $16.47M
High: $16.47M
avg. 0%
Avg: $22.26M
Low: $22.26M
High: $22.26M
avg. 35.16%
Avg: $27.50M
Low: $27.50M
High: $27.50M
avg. 23.54%
Avg: $58.14M
Low: $58.14M
High: $58.14M
avg. 111.38%
Net Income
 
% change YoY
$-59.07M
 
N/A
$-16.58M
 
71.93%
$-15.79M
 
4.74%
Avg: $-32.12M
Low: $-511.24K
High: $-511.24K
avg. -103.37%
Avg: $-42.26M
Low: $-585.23K
High: $-585.23K
avg. -31.58%
Avg: $-733.22K
Low: $-733.22K
High: $-733.22K
avg. 98.26%
Avg: $154.71K
Low: $154.71K
High: $154.71K
avg. 121.10%
EBITDA
 
% change YoY
$-55.63M
 
N/A
$-12.87M
 
76.86%
$-15.74M
 
-22.28%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$27,799.23
 
N/A
-$461.72
 
98.33%
-$46.96
 
89.82%
Avg: -$1.52
Low: -$1.52
High: -$1.52
avg. 96.76%
Avg: -$1.74
Low: -$1.74
High: -$1.74
avg. -14.47%
Avg: -$2.18
Low: -$2.18
High: -$2.18
avg. -25.28%
Avg: $0.46
Low: $0.46
High: $0.46
avg. 121.10%
Operating Expenses
 
% change YoY
$56.70M
 
N/A
$12.67M
 
-77.64%
$15.74M
 
24.16%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is First Wave BioPharma stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 21.10% in 2025-2028.

We have gathered data from 1 analysts. Their low estimate is -511.24K, average is -32.12M and high is -511.24K.

What is First Wave BioPharma stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 42.52% in 2025-2028.

We have gathered data from 1 analysts. Their low revenue estimate is $16.47M, average is $16.47M and high is $16.47M.

What is First Wave BioPharma stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 44.52% in 2025-2028.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$1.52, average is -$1.52 and high is $-1.52.